Stockscreener 앱 받기
177.37
0.34%
0.54
전일 마감가:
$176.83
열려 있는:
$176.78
하루 거래량:
161.21K
Relative Volume:
0.03
시가총액:
$281.88B
수익:
$113.10B
순이익/손실:
$16.33B
주가수익비율:
18.21
EPS:
9.7425
순현금흐름:
$10.35B
1주 성능:
+4.94%
1개월 성능:
+9.28%
6개월 성능:
+34.47%
1년 성능:
+38.00%
1일 변동 폭
$176.78
$177.82
1주일 범위
$168.10
$178.96
52주 변동 폭
$94.33
$178.96
모건 스탠리 Stock (MS) Company Profile
명칭
Morgan Stanley
전화
212-761-4000
주소
1585 BROADWAY, NEW YORK, NY
MS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
177.36 | 281.04B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
867.57 | 259.95B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
94.45 | 167.53B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
135.18 | 122.68B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
372.81 | 29.49B | 14.13B | 1.12B | 45.45M | 14.62 |
모건 스탠리 Stock (MS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | 개시 | BMO Capital Markets | Outperform |
| 2025-07-09 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-09-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-08-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-01-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-01-17 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-11-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-11-20 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | 다운그레이드 | Odeon | Buy → Hold |
| 2023-10-20 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-07 | 개시 | HSBC Securities | Buy |
| 2023-07-12 | 업그레이드 | Odeon | Hold → Buy |
| 2023-01-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-10 | 업그레이드 | Odeon | Sell → Hold |
| 2023-01-04 | 다운그레이드 | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | 다운그레이드 | Odeon | Hold → Sell |
| 2022-05-03 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-01-28 | 다운그레이드 | Odeon | Buy → Hold |
| 2021-12-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | 재확인 | Jefferies | Buy |
| 2021-09-29 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-09-28 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-08-13 | 다운그레이드 | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | 재개 | Keefe Bruyette | Outperform |
| 2021-06-09 | 개시 | Jefferies | Buy |
| 2021-04-21 | 업그레이드 | Berenberg | Hold → Buy |
| 2021-03-02 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | 개시 | Daiwa Securities | Neutral |
| 2021-01-04 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-11-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-10-13 | 재개 | JP Morgan | Overweight |
| 2020-07-08 | 개시 | Seaport Global Securities | Buy |
| 2020-06-24 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2020-06-23 | 재확인 | UBS | Buy |
| 2020-05-21 | 업그레이드 | Odeon | Hold → Buy |
| 2020-04-14 | 업그레이드 | Societe Generale | Sell → Buy |
| 2020-03-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-21 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2020-02-20 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-01-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | 개시 | DA Davidson | Buy |
| 2020-01-06 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-29 | 다운그레이드 | Odeon | Buy → Hold |
| 2019-10-10 | 업그레이드 | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-04-18 | 다운그레이드 | Citigroup | Buy → Neutral |
모두보기
모건 스탠리 주식(MS)의 최신 뉴스
State Street Corp Sells 3,021,615 Shares of Morgan Stanley $MS - MarketBeat
Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO - GlobeNewswire Inc.
Morgan Stanley Downgrades SLM to Equalweight From Overweight, Adjusts PT to $31 From $36 - marketscreener.com
Antero Resources stock price target raised to $48 from $44 at Morgan Stanley - Investing.com
Morgan Stanley raises Paramount Skydance stock price target to $12 on new ownership strategy - Investing.com
Morgan Stanley sees more fuel for European defense stocks rally - TradingView
Morgan Stanley Raises Price Target on Mirum Pharmaceuticals to $95 From $81, Keeps Overweight Rating - marketscreener.com
Morgan Stanley Raises Price Target on Kymera Therapeutics to $127 From $73, Keeps Overweight Rating - marketscreener.com
Morgan Stanley PE Korea head Michael Hwey Hoon Chung steps down after 2 decades - KED Global
Morgan Stanley downgrades Tesla, warns stock reflects full AI and robotics valuation - CBT News
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley Raises Price Target on Dyne Therapeutics to $50 From $46, Keeps Overweight Rating - marketscreener.com
Europe’s Defense Rally Is Just Beginning, Says Morgan Stanley - Bloomberg.com
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley (NYSE:MS) Sets New 52-Week HighTime to Buy? - MarketBeat
Tesla stock slips 3.4% as Morgan Stanley cuts rating to Equal Weight - Traders Union
HelloFresh falls 5% after Morgan Stanley cuts rating on weak ready-to-eat data - Investing.com
Standard Chartered Joins JPMorgan and Morgan Stanley in Fed Rate Cut Call - InsuranceNewsNet
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley reports trading in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley reports trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Trucking Recovery Forecast for 2026: Supply-Side Catalyst Seen by Morgan Stanley - Global Trade Magazine
Morgan Stanley $MS Shares Purchased by Axa S.A. - MarketBeat
Morgan Stanley downgrades HelloFresh stock on ready-to-eat concerns - Investing.com
Morgan Stanley upgrades Ajinomoto stock rating to Overweight on growth prospects - Investing.com
ASM International stock price target raised to EUR625 by Morgan Stanley - Investing.com
Lucid Interim CEO to Speak at the 53rd Annual NASDAQ Investor Conference held in Association with Morgan Stanley - Investing News Network
Morgan Stanley Slams Brakes on Tesla Hype: Downgrades to Hold at $425 on Overheated Valuation - FXLeaders
Open Call: Kellogg-Morgan Stanley Sustainable Investing Challenge - fundsforNGOs
Top 5 Japanese Electronics Stocks to Watch, According to Morgan Stanley - Investing.com
News | Morgan Stanley buys new Amazon warehouse in top-dollar Los Angeles deal - CoStar
Assessing Diamondback Energy (FANG) Valuation After Morgan Stanley’s Endorsement and New Capital Return Moves - simplywall.st
Investment Bank (IB) Morgan Stanley gave a mixed rating on Tesla, causing confusion among investors... - 매일경제
Ex-Morgan Stanley Int’l Broker Seeks to Overturn $1.2 Million Clawback - AdvisorHub
Tesla Shares Drop 4% After Morgan Stanley Downgrade on Valuation Risks - WebProNews
Immix Biopharma Enters Underwriting Agreement with Morgan Stanley - TipRanks
Morgan Stanley raises Descartes stock price target to $110 on strong Q3 - Investing.com
Tesla stock drops as new Morgan Stanley analyst downgrades shares, citing valuation - Yahoo Finance
Morgan Stanley Explains Why Instacart Has an AI-Edge over Its Competitors - TipRanks
Tesla Stock After Hours: Morgan Stanley Downgrade, China Milestone and 0% Deals – What to Know Before the Market Opens on December 9, 2025 - ts2.tech
Ferrari (RACE) Downgraded by Morgan Stanley Amid Growth Concerns - GuruFocus
Tesla downgraded at Morgan Stanley - Yahoo Finance
GM Stock Upgraded to Buy, Lucid Cut to Sell and Other Changes at Morgan Stanley - Barron's
Morgan Stanley Hands Tesla Stock New Rating And Sees Musk Hitting This Many Pay Deal Milestones - Investor's Business Daily
Mirum Pharmaceuticals stock rises as Morgan Stanley reiterates Overweight rating - Investing.com
Fund Files: Franklin to liquidate ESG fund; Morgan Stanley, Pimco plot ETFs - Citywire
Morgan Stanley cuts Tesla's stock rating from 'buy' for the first time in 2 years on valuation concerns - MSN
Form 424B2 MORGAN STANLEY - StreetInsider
Stocks in 2026: What’s Next for Retail Investors - Morgan Stanley
Ferrari Shares Fall After Morgan Stanley Downgrade - marketscreener.com
Morgan Stanley Raises Tesla Target But Downgrades The Stock - Finimize
모건 스탠리 (MS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
0.90%
자본화:
|
볼륨(24시간):